Acrivon Therapeutics Inc (ACRV:NASDAQ)

$1.84 0.16 (9.52%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 89

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Acrivon Therapeutics Inc (ACRV:NASDAQ) News Sources

Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

Yahoo Finance

external link

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress

Yahoo Finance

external link
ACRV stock
ACRV stock price
ACRV stock price today
ACRV stock prediction
ACRV earnings date
ACRV news
ACRV price
ACRV share
ACRV share price
ACRV shares
ACRV ceo
ACRV premarket
$ACRV
ACRV ticker
ACRV after hours
ACRV stock
ACRV stock price
ACRV stock price today
ACRV stock prediction
ACRV earnings date
ACRV news
ACRV price
ACRV share
ACRV share price
ACRV shares
ACRV ceo
ACRV premarket
$ACRV
ACRV ticker
ACRV after hours

Acrivon Therapeutics Inc (ACRV:NASDAQ) FAQs

toggle

What is the current price of Acrivon Therapeutics Inc (ACRV:NASDAQ)?

The current price of Acrivon Therapeutics Inc (ACRV:NASDAQ) is $1.84.


toggle

Acrivon Therapeutics Inc (ACRV:NASDAQ) absolute price change since previous trading day?

The absolute price change of Acrivon Therapeutics Inc (ACRV:NASDAQ) since the previous trading day is $0.16.


toggle

Acrivon Therapeutics Inc (ACRV:NASDAQ) percentage price change since previous trading day?

The percentage price change of Acrivon Therapeutics Inc (ACRV:NASDAQ) since the previous trading day is 9.52%.


toggle

What is This Week's average sentiment score for Acrivon Therapeutics Inc (ACRV:NASDAQ)?

This Week's average sentiment score for Acrivon Therapeutics Inc (ACRV:NASDAQ) is 89 out of 100.


toggle

What is This Week's average sentiment for Acrivon Therapeutics Inc (ACRV:NASDAQ)?

This Week's sentiment for Acrivon Therapeutics Inc (ACRV:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.